Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 104 positions · Total reported value $2.05B · Top-10 concentration 44.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, Rock Springs Capital Management LP disclosed 104 equity positions with a combined reported value of $2.05B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were RVMD ($206.98M), TVTX ($123.79M), LLY ($118.38M). By sector, the heaviest allocations are Health Care 96.8%, Industrials 1.1%. Versus the prior quarter, allocation shifted toward Health Care (+3.3pp) and away from Other (-3.4pp).

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q2 2026 were AVLN ($21.82M), COAG ($21.14M), PBLS ($15.82M).

Of the 8 positions fully exited versus the prior quarter, the largest were ACLX ($19.50M), CNTA ($13.97M), SLNO ($8.61M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • AVLN AVALYN PHARMACEUTICALS INC · $21.82M
  • COAG HEMAB THERAPEUTICS HLDGS INC · $21.14M
  • PBLS PARABILIS MEDICINES INC · $15.82M
  • OMER OMEROS CORP · $6.83M
  • DFTX DEFINIUM THERAPEUTICS INC · $6.74M
  • MOBI MOBIA MED INC · $5.60M
  • TRVI TREVI THERAPEUTICS INC · $4.85M
  • SYRE SPYRE THERAPEUTICS INC · $3.75M

Fully Exited (vs previous quarter)

  • ACLX ARCELLX IN · prev qtr: $19.50M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $13.97M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $8.61M
  • REGN REGENERON PHARMACEUTICALS · prev qtr: $7.80M
  • APLS APELLIS PH · prev qtr: $6.55M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $6.00M
  • XBI SPDR SERIES TRUST · prev qtr: $3.83M
  • EW EDWARDS LIFESCIENCES CORP · prev qtr: $2.31M

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 104 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 44.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
  • Average position size: $19.70M

Sector Tilt

  • Health Care 96.8%
  • Industrials 1.1%
  • Consumer Discretionary 1.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 96.8%
Technology 0.5%
Other 0.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.11M $206.98M 10.10%
10.10%
Reduce
2 2.18M $123.79M 6.04%
6.04%
Add
3 98.70K $118.38M 5.78%
5.78%
Hold
4 175.00K $93.97M 4.59%
4.59%
Add
5 798.14K $93.44M 4.56%
4.56%
Reduce
6 692.60K $76.90M 3.75%
3.75%
Hold
7 453.16K $51.96M 2.54%
2.54%
Reduce
8 52.75K $48.94M 2.39%
2.39%
Reduce
9 168.75K $45.01M 2.20%
2.20%
Reduce
10 683.91K $41.28M 2.02%
2.02%
Reduce
11 715.45K $39.35M 1.92%
1.92%
Reduce
12 362.15K $38.61M 1.89%
1.89%
Add
13 115.75K $36.55M 1.78%
1.78%
Reduce
14 640.32K $34.37M 1.68%
1.68%
Hold
15 967.86K $32.32M 1.58%
1.58%
Reduce
16 269.65K $32.07M 1.57%
1.57%
Add
17 76.46K $30.41M 1.48%
1.48%
Reduce
18 262.60K $28.15M 1.37%
1.37%
Add
19 63.75K $26.50M 1.29%
1.29%
Add
20 699.15K $26.02M 1.27%
1.27%
Add
21 1.40M $25.69M 1.25%
1.25%
Add
22 144.75K $24.40M 1.19%
1.19%
Reduce
23 464.62K $23.58M 1.15%
1.15%
Reduce
24 125.00K $23.39M 1.14%
1.14%
Hold
25 343.00K $23.10M 1.13%
1.13%
Reduce
26 4.33M $22.91M 1.12%
1.12%
Reduce
27 1.52M $22.72M 1.11%
1.11%
Add
28 528.50K $22.56M 1.10%
1.10%
Add
29 648.33K $22.42M 1.09%
1.09%
Hold
30 662.92K $21.82M 1.06%
1.06%
New
31 575.43K $21.14M 1.03%
1.03%
New
32 942.15K $20.93M 1.02%
1.02%
Reduce
33 66.75K $20.09M 0.98%
0.98%
Reduce
34 515.92K $19.97M 0.97%
0.97%
Reduce
35 532.56K $19.76M 0.96%
0.96%
Reduce
36 582.74K $19.75M 0.96%
0.96%
Reduce
37 427.58K $18.35M 0.90%
0.90%
Reduce
38 277.09K $17.44M 0.85%
0.85%
Add
39 573.50K $16.83M 0.82%
0.82%
Hold
40 298.22K $16.46M 0.80%
0.80%
Add
41 187.98K $16.01M 0.78%
0.78%
Add
42 535.29K $15.89M 0.78%
0.78%
Add
43 578.03K $15.82M 0.77%
0.77%
New
44 814.71K $15.48M 0.76%
0.76%
Hold
45 76.30K $14.53M 0.71%
0.71%
Add
46 456.55K $14.27M 0.70%
0.70%
Add
47 2.50M $13.55M 0.66%
0.66%
Reduce
48 162.30K $13.24M 0.65%
0.65%
Hold
49 484.95K $13.08M 0.64%
0.64%
Add
50 502.08K $12.74M 0.62%
0.62%
Hold

FAQ

What did Rock Springs Capital Management LP buy in 2026-Q2?

In its 2026-Q2 13F filing, Rock Springs Capital Management LP reported 104 equity positions worth $2.05B in aggregate; its largest disclosed positions were RVMD ($206.98M), TVTX ($123.79M), LLY ($118.38M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $2.05B of long equity holdings across 104 positions as of 2026-Q2. Top-10 holdings account for 44.0% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →